column
Editor Profile: Guest Editor of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications
2023, 13(4):1345-1345. DOI:10.1016/j.apsb.2023.03.006
Abstract
Editorial of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications
Wei Tao,
2023, 13(4):1346-1347. DOI:10.1016/j.apsb.2023.03.005
Abstract
mRNA delivery in cancer immunotherapy
Yichen Zhong, Shi Du, Yizhou Dong,
2023, 13(4):1348-1357. DOI:10.1016/j.apsb.2023.03.001
Abstract
Recent progress of aptamer-drug conjugates in cancer therapy
Jiaxuan He, Qiao Duan, Chunyan Ran, Ting Fu, Yuan Liu, Weihong Tan,
2023, 13(4):1358-1370. DOI:10.1016/j.apsb.2023.01.017
Abstract
The tumor therapeutic potential of long non-coding RNA delivery and targeting
Shuo Han, Xinru Chen, Leaf Huang,
2023, 13(4):1371-1382. DOI:10.1016/j.apsb.2022.12.005
Abstract
Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome
Nasir Uddin, Daniel W. Binzel, Dan Shu, Tian-Min Fu, Peixuan Guo,
2023, 13(4):1383-1399. DOI:10.1016/j.apsb.2022.11.019
Abstract
Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases
Jingjing Gao, Ziting Xia, Dilrasbonu Vohidova, John Joseph, James N. Luo, Nitin Joshi,
2023, 13(4):1400-1428. DOI:10.1016/j.apsb.2022.07.010
Abstract
Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy
Kamila Butowska, Xuexiang Han, Ningqiang Gong, Rakan El-Mayta, Rebecca M. Haley, Lulu Xue, Wenqun Zhong, Wei Guo, Karin Wang, Michael J. Mitchell,
2023, 13(4):1429-1437. DOI:10.1016/j.apsb.2022.07.011
Abstract
The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
Yang Liu, Wei Xu, Mingxue Li, Yueying Yang, Dejuan Sun, Lidian Chen, Hua Li, Lixia Chen,
2023, 13(4):1438-1466. DOI:10.1016/j.apsb.2022.12.019
Abstract
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
Zi-Han Ye, Wei-Bang Yu, Mu-Yang Huang, Jun Chen, Jin-Jian Lu,
2023, 13(4):1467-1487. DOI:10.1016/j.apsb.2022.12.016
Abstract
The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy
Mingming Zheng, Wenxin Zhang, Xi Chen, Hongjie Guo, Honghai Wu, Yanjun Xu, Qiaojun He, Ling Ding, Bo Yang,
2023, 13(4):1488-1497. DOI:10.1016/j.apsb.2022.10.027
Abstract
Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy
Dan Gao, Sajid Asghar, Rongfeng Hu, Su Chen, Ruixin Niu, Jia Liu, Zhipeng Chen, Yanyu Xiao,
2023, 13(4):1498-1521. DOI:10.1016/j.apsb.2022.11.016
Abstract
AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells
Shaowei Bing, Senfeng Xiang, Zhimei Xia, Yilong Wang, Zhonghai Guan, Jinxin Che, Aixiao Xu, Xiaowu Dong, Ji Cao, Bo Yang, Jinhu Wang, Qiaojun He, Meidan Ying,
2023, 13(4):1522-1536. DOI:10.1016/j.apsb.2023.01.024
Abstract
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
Libin Pan, Hang Yu, Jie Fu, Jiachun Hu, Hui Xu, Zhengwei Zhang, Mengmeng Bu, Xinyu Yang, Haojian Zhang, Jinyue Lu, Jiandong Jiang, Yan Wang,
2023, 13(4):1537-1553. DOI:10.1016/j.apsb.2022.12.010
Abstract
Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis
Yau-tuen Chan, Hor-yue Tan, Yuanjun Lu, Cheng Zhang, Chien-shan Cheng, Junyu Wu, Ning Wang, Yibin Feng,
2023, 13(4):1554-1567. DOI:10.1016/j.apsb.2023.01.020
Abstract
Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis
Sili Zheng, Zhiyong Li, Jie Song, Pin Wang, Jian Xu, Wenjun Hu, Yi Shi, Qi Qi, Zhuwei Miao, Yunfeng Guan, Chaoyu Miao,
2023, 13(4):1568-1587. DOI:10.1016/j.apsb.2022.12.008
Abstract
YAP regulates the liver size during the fasting-refeeding transition in mice
Xuan Li, Shicheng Fan, Chenghui Cai, Yue Gao, Xinhui Wang, Yifei Zhang, Hangfei Liang, Huilin Li, Jie Yang, Min Huang, Huichang Bi,
2023, 13(4):1588-1599. DOI:10.1016/j.apsb.2022.12.011
Abstract
Cholinergic dysfunction-induced insufficient activation of alpha7 nicotinic acetylcholine receptor drives the development of rheumatoid arthritis through promoting protein citrullination via the SP3/PAD4 pathway
Changjun Lv, Minghui Sun, Yilei Guo, Wenxin Xia, Simiao Qiao, Yu Tao, Yulai Fang, Qin Zhang, Yanrong Zhu, Yusufu Yalikun, Yufeng Xia, Zhifeng Wei, Yue Dai,
2023, 13(4):1600-1615. DOI:10.1016/j.apsb.2023.01.016
Abstract
The E3 ubiquitin ligase NEDD4-1 protects against acetaminophen-induced liver injury by targeting VDAC1 for degradation
Yiwei Zhu, Lin Lei, Xinghui Wang, Linfang Chen, Wei Li, Jinxia Li, Chenchen Zhao, Xiliang Du, Yuxiang Song, Wenwen Gao, Guowen Liu, Xinwei Li,
2023, 13(4):1616-1630. DOI:10.1016/j.apsb.2023.01.019
Abstract
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2
Xiaoxi Lv, Shanshan Liu, Chang Liu, Yunxuan Li, Tingting Zhang, Jie Qi, Ke Li, Fang Hua, Bing Cui, Xiaowei Zhang, Yuxin Liu, Jiaojiao Yu, Jinmei Yu, Li Li, Xia Li, Zhigang Yao, Bo Huang,
2023, 13(4):1631-1647. DOI:10.1016/j.apsb.2023.01.008
Abstract
α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo
Yan Shi, Candy Lee, Peng Sang, Zaid Amso, David Huang, Weixia Zhong, Meng Gu, Lulu Wei, Vân T. B. Nguyen-Tran, Jingyao Zhang, Weijun Shen, Jianfeng Cai,
2023, 13(4):1648-1659. DOI:10.1016/j.apsb.2022.10.014
Abstract
Ultrasmall, elementary and highly translational nanoparticle X-ray contrast media from amphiphilic iodinated statistical copolymers
Lu Su, Kellie S. Dalby, Hannah Luehmann, Sussana A. Elkassih, Sangho Cho, Xun He, Lisa Detering, Yen-Nan Lin, Nari Kang, Dennis A. Moore, Richard Laforest, Guorong Sun, Yongjian Liu, Karen L. Wooley,
2023, 13(4):1660-1670. DOI:10.1016/j.apsb.2022.09.009
Abstract
Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria
Yixiang Xu, Chao Zhang, Kai Jiang, Xinchun Yang, Feng Chen, Zhiyang Cheng, Jinlong Zhao, Jiaxing Cheng, Xiaokang Li, Xin Chen, Luoyifan Zhou, Hao Duan, Yunyuan Huang, Yaozu Xiang, Jian Li,
2023, 13(4):1671-1685. DOI:10.1016/j.apsb.2022.08.023
Abstract
Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer
Yongxi Liang, Delin Min, Hulin Fan, Kunlin Liu, Juchuanli Tu, Xueyan He, Bingjie Liu, Lu Zhou, Suling Liu, Xun Sun,
2023, 13(4):1686-1698. DOI:10.1016/j.apsb.2022.11.023
Abstract
Spatiotemporally resolved metabolomics and isotope tracing reveal CNS drug targets
Bo Jin, Xuechao Pang, Qingce Zang, Man Ga, Jing Xu, Zhigang Luo, Ruiping Zhang, Jiangong Shi, Jiuming He, Zeper Abliz,
2023, 13(4):1699-1710. DOI:10.1016/j.apsb.2022.11.011
Abstract
Self-assembled multifunctional nanotheranostics against circulating tumor clusters in metastatic breast cancer
Ramya Dhandapani, Swaminathan Sethuraman, Uma Maheswari Krishnan, Anuradha Subramanian,
2023, 13(4):1711-1725. DOI:10.1016/j.apsb.2022.12.003
Abstract
Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis
Zhihui Han, Xiang Gao, Yuanjie Wang, Shuning Cheng, Xiaoyan Zhong, Yong Xu, Xiaozhong Zhou, Zengli Zhang, Zhuang Liu, Liang Cheng,
2023, 13(4):1726-1739. DOI:10.1016/j.apsb.2022.11.020
Abstract
On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition
Xiaoqing Liu, Shuang Liang, Xiao Sang, Lili Chang, Shunli Fu, Han Yang, Huizhen Yang, Yongjun Liu, Na Zhang,
2023, 13(4):1740-1754. DOI:10.1016/j.apsb.2022.09.004
Abstract
A novel biological sources consistency evaluation method reveals high level of biodiversity within wild natural medicine: A case study of Amynthas earthworms as “Guang Dilong”
Zhimei Xing, Han Gao, Dan Wang, Ye Shang, Tenukeguli Tuliebieke, Jibao Jiang, Chunxiao Li, Hong Wang, Zhenguo Li, Lifu Jia, Yongsheng Wu, Dandan Wang, Wenzhi Yang, Yanxu Chang, Xiaoying Zhang, Liuwei Xu, Chao Jiang, Luqi Huang, Xiaoxuan Tian,
2023, 13(4):1755-1770. DOI:10.1016/j.apsb.2022.10.024
Abstract
Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agent
Yuyu Liu, Xinnan Li, Songyang Sui, Jingshu Tang, Dawei Chen, Yuying Kang, Kebo Xie, Jimei Liu, Jiaqi Lan, Lei Wu, Ridao Chen, Ying Peng, Jungui Dai,
2023, 13(4):1771-1785. DOI:10.1016/j.apsb.2022.10.007
Abstract
Commentary: Can FXR serve as a potential target for COVID-19 prevention?
Juan Pang, Jia Nuo Feng, Wenhua Ling, Tianru Jin,
2023, 13(4):1786-1788. DOI:10.1016/j.apsb.2023.01.023
Abstract

Copyright © 2014 Editorial Office of Acta Pharmaceutica Sinica